These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3258863)

  • 1. Enoxacin in the treatment of lower respiratory tract infections.
    Philip-Joet F; Nourrit J; Frances Y; Arnaud A
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():125-9. PubMed ID: 3258863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
    Prigogine T; Glupczynski Y; Carpiaux JP; Blogie M; Yourassowsky E; Schmerber JS
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():131-6. PubMed ID: 3129390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New oral quinolone compounds in chronic bronchitis].
    Davies BI; Maesen FP; Teengs JP; Baur C
    Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Baur C
    Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
    Kemmerich B; Borner K; Pennington JE
    Antimicrob Agents Chemother; 1987 Mar; 31(3):417-20. PubMed ID: 3495234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ofloxacin therapy for lower respiratory tract infection.
    Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
    South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia.
    Scribner RK; Welch DF; Marks MI
    J Antimicrob Chemother; 1985 Nov; 16(5):597-603. PubMed ID: 3865924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolones in the treatment of bronchopulmonary infections.
    Thys JP
    Rev Infect Dis; 1988; 10 Suppl 1():S212-7. PubMed ID: 3279495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():113-8. PubMed ID: 3258862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the 4-quinolone enoxacin on plasma theophylline concentrations.
    Wijnands WJ; Vree TB; Van Herwaarden CL
    Pharm Weekbl Sci; 1986 Feb; 8(1):42-5. PubMed ID: 3457357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of miocamycin in respiratory tract diseases].
    Rimoldi R; Fioretti M; Bandera M
    Ann Ist Super Sanita; 1987; 23(4):891-4. PubMed ID: 3502553
    [No Abstract]   [Full Text] [Related]  

  • 19. Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
    Heifetz CL; Bien PA; Cohen MA; Dombrowski ME; Griffin TJ; Malta TE; Sesnie JC; Shapiro MA; Wold SA
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():29-42. PubMed ID: 3129392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.